Intrathecal baclofen therapy and spinal cord stimulation in the treatment of spasticity in patients due to spinal cord injury: results of 6 month follow up
Abstract
Spasticity is one of the most common complications of spinal cord injury (SCI), the treatment of which is still an unresolved problem. Our goal was to develop an algorithm for personalized selection of patients for surgical treatment using spinal stimulation (SCS) and intrathecal baclofen therapy (ITB ).
We analyzed 28 cases of severe spastic syndrome in patients with SCI, aged 18 to 62 years, with an average age of 33.9 ± 12.9. The patients were divided into 3 groups: the control group that received conservative therapy; the SCS group and the ITB group. The results were evaluated using a modified Ashworth scale, Pen spasm frequency scale, reflex scale, and motor function scale 1, 3 and 6 months after surgery. The first stage was carried out trial SCS in case of positive result of the performed implantation of a pulse generator (14 patients), with a negative result, the patient was performed baclofen trial, the results of which have been implanted pump (14 patients).
As a result, over 6 months of observation obtained the significant decline in spasticity in both study groups compared to the control for all scales except the scale of motor function, where there were no recorded statistically significant changes.
Based on the results of 6-month follow-up, we can make a preliminary conclusion that step-by-step selection through test stimulation is an effective method of personalized treatment of spasticity. Patients who responded to the trial SCS maintain a stable result for a long period of time without detecting significant differences with those receiving ITB .
About the Authors
A. R. BiktimirovRussian Federation
Vladivostok
O. I. Pak
Russian Federation
Vladivostok
R. I. Totorkulov
Russian Federation
Vladivostok
I. S. Bryukhovetsky
Russian Federation
Vladivostok
References
1. Kumar R, Traumatic Spinal Injury: Global Epidemiology and Worldwide Volume/ Kumar R, Lim J, Mekary R, Rattani A, Dewan M, Sharif S, Osorio-Fonseca E, Park K.B //World Neurosurg., 113 (2018) 345‑363.
2. D evivo M, Epidemiology of traumatic spinal cord injury: trends and future implications/ Devivo M // Spinal Cord. 2012 50 (5) 365‑72
3. https://www.nscisc.uab.edu/PublicDocuments/fact_figures_docs/Facts%202014.pdf
4. Spinal Cord Injury (SCI) 2016 Facts and Figures at a Glance // J Spinal Cord Med. 2016 39(4):493–4
5. A dams M, Spasticity after spinal cord injury / Adams M, Hicks A // Spinal Cord 43 (2005) 577‑586.
6. Nagel S, Spinal Cord Stimulation for Spasticity: Historical Approaches, Current Status, and Future Directions / Nagel S, Wilson S, Johnson M, Machado A, Frizon L, Chardon M, Reddy C, Gillies G, Howard M // Neuromodulation: Technology at the Neural Interface, 4 (2017) vol. 20 number 4 307–321.
7. P inter M, Epidural electrical stimulation of posterior structures of the human lumbosacral cord: 3. Control of spasticity / Pinter M, Gerstenbrand F, Dimitrijevic M // Spinal Cord 38 (2000) 524‑531.
8. D ekopov A, Chronic spinal cord stimulation in the treatment of cerebral and spinal spasticity / Dekopov A, Shabalov V, Tomsky A, Hit M, Salova E // Stereotact. Funct. Neurosurg. 93 (2015) 133‑139.
9. Barolat G, Epidural spinal cord stimulation in the management of spasms in spinal cord injury: a prospective study / Singh-Sahni K, Staas W, Shatin D, Ketcik B, Allen K // Stereotact. Funct. Neurosurg. 64 (1995) 153‑164.
10. Saulino M, Best practices for intrathecal baclofen therapy: troubleshooting / Saulino M, Anderson DJ , Doble J, Farid R, Gul F, Konrad P, Boster AL // Neuromodulation: technology at the neural interface, 6 (2016) vol. 19 632–641.
11. Boster AL , Best practices for intrathecal baclofen therapy: screening test / Boster AL , Bennett SE, Bilsky GS, Gudesblatt M, Koelbel SF, McManus M, Saulino M // Neuromodulation: technology at the neural interface, 6 (2016) vol. 19 616–622.
12. Boster AL , Best practices for intrathecal baclofen therapy: dosing and long–term management / Boster AL , Adair RL , Gooch JL , Nelson ME , Toomer A, Urquidez J, Saulino M // Neuromodulation: technology at the neural interface, 6 (2016) vol. 19 623–631
13. Saulino M, Best practices for intrathecal baclofen therapy: patient selection / Saulino M, Ivanhoe CB, McGuire JR , Ridley B, Shilt JS, Boster AL // Neuromodulation: technology at the neural interface, 6 (2016) vol. 19 607–615.
14. C ook W, Chronic dorsal column stimulation in multiple sclerosis / Cook W, Weinstein SP // NY State J Med (1973) 73 2868–2872
15. P enn RD , Intrathecal baclofen alleviates spinal cord spasticity / Penn RD , Kroin JS // Lancet. (1984)1 1078
16. Pucks-Faes E, Eleven years’ experience with intrathecal baclofen — complications, risk factors / Pucks-Faes E, Hitzenberger G, Matzak H, Fava E, Verrienti G, Laimer I, Fritz J, Saltuari L // Brain Behav. (2018) 8(5).
17. Winter G, Intrathecal baclofen therapy — practical approach: clinical benefits and complication management / Winter G, Beni-Adani L, Ben-Pazi HJ // Child. Neurol. (2018) 33(11) 734–741.
18. M otta F, Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience / Motta F, Antonello CE //J. neurosurg. pediatr. (2014) 13(3) 301–6
19. Eldabe S, Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature / Eldabe S, Buchser E, Duarte RV // Pain Med. (2016) 17(2) 325–336.
Review
For citations:
Biktimirov A.R., Pak O.I., Totorkulov R.I., Bryukhovetsky I.S. Intrathecal baclofen therapy and spinal cord stimulation in the treatment of spasticity in patients due to spinal cord injury: results of 6 month follow up. Russian Neurosurgical Journal named after Professor A. L. Polenov. 2020;12(4):6-13. (In Russ.)